Groupe Eurotunnel: Shuttle Traffic for Full Year 2016
Get Alerts GET Hot Sheet
Join SI Premium – FREE
PARIS--(BUSINESS WIRE)--
Regulatory News:
Groupe Eurotunnel (Paris: GET):
Dec-16 | Dec-15 | Change |
Full Year2016 |
Full Year 2015 |
Change | ||||||||||
Truck Shuttles | Trucks | 131,906 | 130,607 | +1% | 1,641,638 | 1,483,741 | +11% | ||||||||
Passenger Shuttles |
Passenger vehicles* |
232,164 | 219,109 | +6% | 2,663,865 | 2,614,972 | +2% |
*Includes cars, motorcycles, vehicles with trailers, caravans, camper vans and coaches
For the full year 2016, Truck Shuttle traffic increased by 11% compared to 2015, with an all-time record of 1,641,638 vehicles transported. For the fourteenth consecutive month, December 2016 saw record-breaking monthly Truck Shuttle traffic compared to the corresponding period in previous years.
For the full year 2016, Passenger Shuttle traffic increased by +2% compared to 2015, with 2,663,865 vehicles transported. In December 2016, the traffic increased by +6% compared to the month of December 2015 confirming the upward trend observed over the last three months.
The Eurotunnel Group ‘s revenues for the year 2016 will be published on Tuesday 24 January 2017 prior to the opening of trading.
The traffic figures for the month of January will be published on Monday 13 February 2017 prior to the opening of trading.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170109006342/en/
Eurotunnel:
For UK
media enquiries
John Keefe on + 44 (0) 1303 284491
Email:
[email protected]
or
For
other media enquiries
Anne-Laure Desclèves on +33(0)1
4098 0467
or
For investor enquiries:
Jean-Baptiste
Roussille on +33 (0)1 40 98 04 81
Email: [email protected]
or
Michael
Schuller on +44 (0) 1303 288749
Email: [email protected]
Source: Groupe Eurotunnel SE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bioforum the Data Masters Introduces SUBMIT24: A Free of Charge and Revolutionary CDISC CORE-Based Clinical Data Validation Tool
- NeuroNexus is Leveraging Bioz's AI-Powered Citation Tools to Drive Increased Sales Conversion
- Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!